Compare SEER & QTRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SEER | QTRX |
|---|---|---|
| Founded | 2017 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Biotechnology: Laboratory Analytical Instruments |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 113.0M | 135.3M |
| IPO Year | 2020 | 2017 |
| Metric | SEER | QTRX |
|---|---|---|
| Price | $1.74 | $2.84 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 2 | 3 |
| Target Price | ★ $4.00 | $3.17 |
| AVG Volume (30 Days) | 167.0K | ★ 460.0K |
| Earning Date | 11-10-2026 | 11-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 9.40 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $16,578,000.00 | ★ $37,632,000.00 |
| Revenue This Year | N/A | $3.21 |
| Revenue Next Year | $20.50 | $9.96 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | 16.99 | ★ 64.52 |
| 52 Week Low | $1.55 | $2.15 |
| 52 Week High | $2.38 | $8.77 |
| Indicator | SEER | QTRX |
|---|---|---|
| Relative Strength Index (RSI) | 32.98 | 42.24 |
| Support Level | $1.70 | $2.40 |
| Resistance Level | $1.81 | $2.83 |
| Average True Range (ATR) | 0.10 | 0.18 |
| MACD | -0.04 | -0.01 |
| Stochastic Oscillator | 25.00 | 22.52 |
Seer Inc is a life sciences company, develops and commercializes products to decode the biology of the proteome. The company offers Proteograph Product Suite, an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation, and data analysis software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only. It markets and sells its products for research use only, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. The company operates in China, Australia, Eastern Europe, Israel, Japan and South Africa.
Quanterix Corp is a life sciences company accelerating biomarker breakthroughs from discovery to diagnostics using ultra-sensitive translational research and spatial biology instruments, consumables, and services. The company sells proprietary instruments and related consumables to research laboratories, contract research organizations (CROs), academic institutions, and bio-pharmaceutical companies, and provides contract research services and clinical laboratory testing services, including four Laboratory Developed Tests (LDTs), through its Accelerator Laboratory. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, and SP-X Imaging and Analysis System. Geographically, it operates in North America, EMEA, and the Asia Pacific.